| Characteristic | Univariable | Multivariable | |||||
|---|---|---|---|---|---|---|---|
| N | HR1 | 95% CI1 | p-value | HR1 | 95% CI1 | p-value | |
| Treatment Groups | 2,330 | ||||||
| Neoadjuvant Multiagent Chemotherapy | — | — | — | — | |||
| Postop Multiagent Chemotherapy | 1.83 | 1.65, 2.03 | <0.001 | 1.62 | 1.39, 1.89 | <0.001 | |
| Age | 2,330 | ||||||
| <51 | — | — | — | — | |||
| >75 | 1.23 | 1.00, 1.52 | 0.045 | 1.16 | 0.90, 1.49 | 0.3 | |
| 51-75 | 0.92 | 0.81, 1.05 | 0.2 | 0.97 | 0.82, 1.15 | 0.8 | |
| Type of Insurance | 2,297 | ||||||
| Medicaid | — | — | |||||
| Medicare | 1.03 | 0.81, 1.32 | 0.8 | ||||
| Not Insured | 1.28 | 0.83, 1.95 | 0.3 | ||||
| Private Insurance/Managed Care/Goverment | 0.93 | 0.73, 1.18 | 0.5 | ||||
| No High School Degree | 2,322 | ||||||
| <7.0% | — | — | |||||
| >=21.0% | 1.07 | 0.89, 1.27 | 0.5 | ||||
| 13.0-20.9% | 0.99 | 0.87, 1.14 | >0.9 | ||||
| 7.0-12.9% | 0.95 | 0.85, 1.07 | 0.4 | ||||
| TNM Clinical T | 2,105 | ||||||
| c0 | — | — | |||||
| c1 | 1.47 | 0.20, 10.8 | 0.7 | ||||
| c2 | 1.45 | 0.20, 10.4 | 0.7 | ||||
| c3 | 1.02 | 0.14, 7.28 | >0.9 | ||||
| c4 | 1.03 | 0.14, 7.31 | >0.9 | ||||
| TNM Clinical N | 2,082 | ||||||
| c0 | — | — | |||||
| c1 | 1.01 | 0.91, 1.13 | 0.8 | ||||
| Clinical Downstaging | 1,653 | ||||||
| No | — | — | — | — | |||
| Yes | 0.64 | 0.57, 0.73 | <0.001 | 0.74 | 0.64, 0.84 | <0.001 | |
|
1
HR = Hazard Ratio, CI = Confidence Interval
|
|||||||